Still's Disease

1

Review clinical trials related to Still's Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

The study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 (arumakimig) in pediatric and adult participants with Still's disease

Participants needed: 30
Trial details
Phase: Phase 2Age: 1+Biological sex: AllType: InterventionalSponsor: Novartis PharmaceuticalsUpdated: Aug 19, 2026Locations: 23
Eligibility criteria

Age ≥ 1 with a diagnosis of Still's Disease [+6]

Patients out of weight range [+12]